REFERENCES:

Bijker N et al. Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001;19:2263-71. Abstract

Bijker N et al. Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ. Br J Cancer 2001;84:539-44. Abstract

Bijker N et al. Breast-conserving therapy for Paget disease of the nipple: A prospective European Organization for Research and Treatment of Cancer study of 61 patients. Cancer 2001;91:472-7. Abstract

Bijker N et al. Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS. Eur J Surg Oncol 2001;27:135-40. Abstract

Bordeleau L et al. A comparison of four treatment strategies for ductal carcinoma in situ using decision analysis. Cancer 2001;92:23-9. Abstract

Chan KC et al. Blockade of growth factor receptors in ductal carcinoma in situ inhibits epithelial proliferation. Br J Surg 2001;88:412-8. Abstract

Chan KC et al. Extent of excision margin width required in breast conserving surgery for ductal carcinoma in situ. Cancer 2001;91:9-16. Abstract

Cox CE et al. Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): Why map DCIS? Am Surg 2001;67:513-9; discussion 519-21. Abstract

Crombie N et al. Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma. Br J Surg 2001;88:1324-9. Abstract

Fahy BN et al. Cost-benefit analysis of biopsy methods for suspicious mammographic lesions; Discussion 994-5. Arch Surg 2001;136:990-4. Abstract

Farshid G et al. Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation. Virchows Arch 2001;439:70-7. Abstract

Faverly DR et al. Breast carcinomas of limited extent: Frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer 2001;91:647-59. Abstract

Fisher B et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: An update of the National Surgical Adjuvant Breast and Bowel Project experience. Semin Oncol 2001;28:400-18. Abstract

Gupta D et al. Metastases to breast simulating ductal carcinoma in situ: Report of two cases and review of the literature. Ann Diagn Pathol 2001;5:15-20. Abstract

Horiguchi J et al. Recurrence of breast cancer following local excision alone for ductal carcinoma in situ. Breast Cancer 2001;8:52-7. Abstract

Iwase H et al. Immunohistochemical analysis on biological markers in ductal carcinoma in situ of the breast. Breast Cancer 2001;8:98-104. Abstract

Jenkinson AD et al. Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies. Eur J Surg Oncol 2001;27:21-5. Abstract

Jha MK et al. Aggressive local treatment for screen-detected DCIS results in very low rates of recurrence. Eur J Surg Oncol 2001;27:454-8. Abstract

Katz SJ et al. Correlates of surgical treatment type for women with noninvasive and invasive breast cancer. J Womens Health Gend Based Med 2001;10:659-70. Abstract

King TA et al. A mass on breast imaging predicts coexisting invasive carcinoma in patients with a core biopsy diagnosis of ductal carcinoma in situ. Am Surg 2001;67:907-12. Abstract

Kokubo M et al. Results of breast-conserving therapy for ductal carcinoma in situ: The Kyoto University experiences. Breast Cancer 2001;8:153-7. Abstract

Leal C et al. Apocrine ductal carcinoma in situ of the breast: Histologic classification and expression of biologic markers. Hum Pathol 2001;32:487-93. Abstract

Lucci A Jr et al. National practice patterns of sentinel lymph node dissection for breast carcinoma. J Am Coll Surg 2001;192:453-8. Abstract

Mendez I et al. Ductal carcinoma in situ and atypical ductal hyperplasia of the breast diagnosed at stereotactic core biopsy. Breast J 2001;7:14-8. Abstract

Mokbel K et al. Predictors of positive margins after local excision of ductal carcinoma in situ. Am J Surg 2001;181:91-5. Abstract

Oh YL et al. Expression of p21Waf1, p27Kip1 and cyclin D1 proteins in breast ductal carcinoma in situ: Relation with clinicopathologic characteristics and with p53 expression and estrogen receptor status. Pathol Int 2001;51:94-9. Abstract

Poller DN. Pathology of ductal carcinoma in situ of the breast: Current status. Eur J Surg Oncol 2001;27:498-503. Abstract

Ringberg A et al. Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics. Eur J Cancer 2001;37:1514-22. Abstract

Rosenfeld I et al. The significance of malignancies incidental to microcalcifications in breast spot localization biopsy specimens. Am J Surg 2001;182:1-5. Abstract

Skinner KA, Silverstein MJ. The management of ductal carcinoma in situ of the breast. Endocr Relat Cancer 2001;8:33-45. Full-Text

Solin LJ et al. Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: Long-term outcome and prognostic significance of patient age and margin status. Int J Radiat Oncol Biol Phys 2001;50:991-1002. Abstract

Solin LJ et al. Salvage treatment for local recurrence after breast-conserving surgery and radiation as initial treatment for mammographically detected ductal carcinoma in situ of the breast. Cancer 2001;91:1090-7. Abstract

Stallard S et al. Ductal carcinoma in situ of the breast — Among factors predicting for recurrence, distance from the nipple is important. Eur J Surg Oncol 2001;27:373-7. Abstract

Takeda A et al. Breast-conserving therapy for ductal carcinoma in situ. Oncol Rep 2001;8:835-9. Abstract

Vicini FA et al. Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy. J Surg Oncol 2001;76:245-54. Abstract

Wahedna Y et al. Mammographic size of ductal carcinoma in situ does not predict the presence of an invasive focus. Eur J Cancer 2001;37:459-62. Abstract

Warnberg F et al. Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: A population-based case-control study in Sweden. Cancer Epidemiol Biomarkers Prev 2001;10:495-9. Abstract

Back | Top of Page